Colgate-Palmolive (NYSE:CL) Shares Acquired by New York Life Investment Management LLC

New York Life Investment Management LLC increased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 0.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 128,906 shares of the company’s stock after acquiring an additional 336 shares during the quarter. New York Life Investment Management LLC’s holdings in Colgate-Palmolive were worth $10,275,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. OFI Invest Asset Management bought a new position in shares of Colgate-Palmolive during the third quarter worth about $25,000. Avion Wealth grew its position in Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after purchasing an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $34,000. Kayne Anderson Rudnick Investment Management LLC increased its stake in shares of Colgate-Palmolive by 142.0% in the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after purchasing an additional 291 shares during the period. Finally, West Branch Capital LLC boosted its position in shares of Colgate-Palmolive by 24.0% during the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after buying an additional 132 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

CL opened at $91.63 on Thursday. The business has a fifty day simple moving average of $88.08 and a 200-day simple moving average of $81.99. The firm has a market cap of $75.18 billion, a PE ratio of 29.08, a P/E/G ratio of 3.39 and a beta of 0.40. The company has a quick ratio of 0.28, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $92.54.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. The business had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. Colgate-Palmolive’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter last year, the company posted $0.73 EPS. As a group, equities analysts predict that Colgate-Palmolive will post 3.52 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.18%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s payout ratio is currently 63.29%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Jennifer Daniels sold 5,790 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $83.96, for a total transaction of $486,128.40. Following the transaction, the insider now directly owns 63,236 shares in the company, valued at approximately $5,309,294.56. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other Colgate-Palmolive news, insider Jennifer Daniels sold 5,790 shares of the firm’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $83.96, for a total transaction of $486,128.40. Following the completion of the sale, the insider now directly owns 63,236 shares in the company, valued at approximately $5,309,294.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the transaction, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. In the last 90 days, insiders sold 159,048 shares of company stock worth $13,336,846. 0.34% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms recently commented on CL. Barclays raised their target price on Colgate-Palmolive from $84.00 to $85.00 and gave the company an “equal weight” rating in a research report on Tuesday. Raymond James upgraded shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective on the stock in a research note on Monday, January 29th. StockNews.com cut shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. Royal Bank of Canada boosted their price target on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Monday. Finally, Stifel Nicolaus raised their price objective on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a research note on Monday. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $91.44.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.